Evercore Wealth Management’s AbbVie ABBV Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$20.1M Sell
79,804
-2,075
-3% -$446K 0.28% 54
2026
Q1
$17.8M Sell
81,879
-2,021
-2% -$448K 0.28% 52
2025
Q4
$19.2M Sell
83,900
-1,470
-2% -$335K 0.28% 52
2025
Q3
$19.8M Sell
85,370
-736
-0.9% -$150K 0.29% 52
2025
Q2
$16M Sell
86,106
-721
-0.8% -$134K 0.25% 54
2025
Q1
$18.2M Sell
86,827
-679
-0.8% -$132K 0.29% 51
2024
Q4
$15.5M Sell
87,506
-679
-0.8% -$125K 0.23% 55
2024
Q3
$17.4M Sell
88,185
-1,653
-2% -$309K 0.26% 51
2024
Q2
$15.4M Sell
89,838
-372
-0.4% -$61.6K 0.24% 53
2024
Q1
$16.4M Sell
90,210
-2,106
-2% -$363K 0.26% 52
2023
Q4
$14.3M Sell
92,316
-442
-0.5% -$64.4K 0.24% 55
2023
Q3
$13.8M Sell
92,758
-4,104
-4% -$602K 0.26% 55
2023
Q2
$13.1M Sell
96,862
-126
-0.1% -$18.5K 0.24% 58
2023
Q1
$15.5M Buy
96,988
+1,847
+2% +$282K 0.31% 51
2022
Q4
$15.4M Sell
95,141
-1,926
-2% -$295K 0.32% 51
2022
Q3
$13M Sell
97,067
-1,802
-2% -$259K 0.29% 54
2022
Q2
$15.1M Sell
98,869
-601
-0.6% -$91.8K 0.32% 52
2022
Q1
$16.1M Sell
99,470
-35
-0% -$5.08K 0.29% 56
2021
Q4
$13.5M Sell
99,505
-1,321
-1% -$156K 0.22% 61
2021
Q3
$10.9M Sell
100,826
-1,210
-1% -$138K 0.2% 63
2021
Q2
$11.5M Sell
102,036
-7,939
-7% -$894K 0.21% 61
2021
Q1
$11.9M Buy
109,975
+334
+0.3% +$35.7K 0.24% 59
2020
Q4
$11.7M Buy
109,641
+622
+0.6% +$59.8K 0.25% 56
2020
Q3
$9.55M Sell
109,019
-418
-0.4% -$39.4K 0.23% 59
2020
Q2
$10.7M Buy
109,437
+4,144
+4% +$365K 0.29% 56
2020
Q1
$8.02M Buy
105,293
+1,340
+1% +$114K 0.26% 60
2019
Q4
$9.2M Buy
103,953
+1,955
+2% +$162K 0.25% 64
2019
Q3
$7.72M Sell
101,998
-2,478
-2% -$170K 0.23% 70
2019
Q2
$7.6M Buy
104,476
+12,819
+14% +$1.01M 0.23% 69
2019
Q1
$7.39M Buy
91,657
+6,206
+7% +$508K 0.24% 71
2018
Q4
$7.88M Sell
85,451
-1,463
-2% -$129K 0.3% 66
2018
Q3
$8.22M Sell
86,914
-11,272
-11% -$1.07M 0.26% 67
2018
Q2
$9.1M Buy
98,186
+705
+0.7% +$68.9K 0.31% 62
2018
Q1
$9.23M Sell
97,481
-2,291
-2% -$252K 0.35% 59
2017
Q4
$9.65M Sell
99,772
-3,517
-3% -$331K 0.36% 55
2017
Q3
$9.18M Sell
103,289
-61
-0.1% -$4.64K 0.36% 56
2017
Q2
$7.49M Sell
103,350
-10,256
-9% -$689K 0.29% 68
2017
Q1
$7.4M Sell
113,606
-4,595
-4% -$289K 0.29% 70
2016
Q4
$7.4M Buy
118,201
+6,515
+6% +$398K 0.31% 71
2016
Q3
$7.04M Buy
111,686
+8,574
+8% +$555K 0.29% 69
2016
Q2
$6.38M Sell
103,112
-1,037
-1% -$63.2K 0.28% 73
2016
Q1
$5.95M Sell
104,149
-419
-0.4% -$23.4K 0.26% 75
2015
Q4
$6.19M Buy
104,568
+1,608
+2% +$92.6K 0.29% 75
2015
Q3
$5.6M Buy
102,960
+2,890
+3% +$188K 0.27% 82
2015
Q2
$6.73M Sell
100,070
-974
-1% -$63.6K 0.3% 74
2015
Q1
$5.92M Buy
101,044
+2,550
+3% +$154K 0.27% 84
2014
Q4
$6.44M Sell
98,494
-2,192
-2% -$138K 0.32% 74
2014
Q3
$5.82M Buy
100,686
+3,587
+4% +$199K 0.29% 83
2014
Q2
$5.48M Buy
97,099
+9,969
+11% +$523K 0.28% 82
2014
Q1
$4.48M Sell
87,130
-18,728
-18% -$947K 0.25% 92
2013
Q4
$5.59M Sell
105,858
-38,800
-27% -$1.91M 0.31% 90
2013
Q3
$6.47M Buy
144,658
+1,092
+0.8% +$48.4K 0.37% 80
2013
Q2
$5.93M Buy
+143,566
New +$6.28M 0.34% 82

Other funds holding ABBV

Evercore Wealth Management's ABBV Position: Q2 2026 in Review

Evercore Wealth Management reduced its AbbVie (ABBV) stake by 2.5% in Q2 2026, selling an estimated $446K and leaving 79,804 shares worth $20.1M. The position accounts for 0.28% of the portfolio, ranked #54.

Evercore Wealth Management first reported a position in ABBV in Q2 2013 and has held it in 53 quarters since. 4,189 funds tracked by Wall St. Rank hold ABBV as of Q2 2026.

  • Evercore Wealth Management held 79,804 shares of AbbVie worth $20.1M as of Q2 2026.
  • Evercore Wealth Management sold 2,075 AbbVie shares in Q2 2026, an estimated $446K.
  • AbbVie made up 0.28% of Evercore Wealth Management's portfolio in Q2 2026, its #54 holding.
  • Evercore Wealth Management first reported a position in AbbVie in Q2 2013 and has held it in 53 quarters since.
  • 4,189 funds tracked by Wall St. Rank held AbbVie as of Q2 2026.

Based on Evercore Wealth Management's 13F filing for Q2 2026, filed 14 Aug 2026.